Menu

Caught on Camera

Selected Images of the Day from the-scientist.com

Sep 1, 2018
The Scientist Staff
BEATING HEART: Scientists developed an open-source stem cell line with fluorescent tags—these mark troponin l1—for cardiac cells.
Posted: July 2, 2018
Allen Institute


MUSCLE MOSAIC: A newly developed staining technique to characterize rodent muscle fibers (rat plantaris muscle shown here) paints cells four different colors.
Posted: November 11, 2016
 S. Sawano et al., PLOS ONE, doi:10.1371/journal.pone.0166080, 2016.


3-D NANOFIBERS: Researchers created a 3-D model of synthetic nanofibers, such as these fibers (pink) surrounded by cardiac muscle cells (purple), to learn how to engineer more efficient scaffolds for biomedical applications. Posted: March 7, 2018
V. Balashov et al., Acta Biomaterialia, doi:10.1016/j.actbio.2017.12.031, 2018


COLD HEARTED: Cardiologists can now cool the human heart in a localized way to help reduce muscle damage from heart attacks. The dark spot at lower left is the cooled portion. Posted: January 22, 2018
Catharina Hospital, Eindhoven


MUSCLE BOUQUET: Culture-grown muscle stem cells from mice, which have fused together to form myotubes (some of them fluorescently labeled in green), showing cell nuclei (blue) and distinct striations (red) Posted: January 16, 2018
Kevin Murach, University of Kentucky College of Health Sciences

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.